Glutamatergic receptor activation in the rostral ventrolateral medulla mediates the sympathoexcitatory response to hyperinsulinemia

Hypertension

Volumn 55, Issue 2, 2010, Pages 284-290

  Bardgett, Megan E ^a,b   McCarthy, John J ^a   Stocker, Sean D ^a  

^a PENN STATE COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF KENTUCKY   (United States)

Author keywords

Arterial blood pressure; Insulin; Obesity; RVLM; Sympathetic nerve activity

Indexed keywords

CHLORALOSE; GLUCOSE; GLUTAMATE RECEPTOR; INSULIN; INSULIN RECEPTOR; KYNURENIC ACID; LOSARTAN; MELANOCORTIN; MELANOCORTIN RECEPTOR; N ACETYL ALPHA INTERMEDIN[4-10]CYCLO[4 NORLEUCINE 5 ASPARTIC ACID 7 [3 (2 NAPHTHYL)ALANINE] 10 LYSINAMIDE]; N METHYL DEXTRO ASPARTIC ACID; NEUROTRANSMITTER;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; GLUCOSE BLOOD LEVEL; HYPERINSULINEMIA; HYPOTHALAMUS; INSULIN BLOOD LEVEL; INSULIN INFUSION; MALE; MEDULLA OBLONGATA; MICROINJECTION; NONHUMAN; PRIORITY JOURNAL; RAT; WESTERN BLOTTING;

ANALYSIS OF VARIANCE; ANIMALS; BLOTTING, WESTERN; DISEASE MODELS, ANIMAL; EXCITATORY AMINO ACID ANTAGONISTS; HYPERINSULINISM; INSULIN; LOSARTAN; MALE; MEDULLA OBLONGATA; PROBABILITY; RANDOM ALLOCATION; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, INSULIN; RECEPTORS, GLUTAMATE; RECEPTORS, N-METHYL-D-ASPARTATE; SYMPATHETIC NERVOUS SYSTEM;

EID: 74949087576     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/HYPERTENSIONAHA.109.146605     Document Type: Article

References (45)

1. Esler M, Straznicky N, Eikelis N, Masuo K, Lambert G, Lambert E. Mechanisms of sympathetic activation in obesity-related hypertension. Hypertension. 2006;48:787-796.
2. Wofford MR, Hall JE. Pathophysiology and treatment of obesity hypertension. Curr Pharm Des. 2004;10:3621-3637.
3. Rumantir MS, Vaz M, Jennings GL, Collier G, Kaye DM, Seals DR, Wiesner GH, Brunner-La Rocca HP, Esler MD. Neural mechanisms in human obesity-related hypertension. J Hypertens. 1999;17:1125-1133.
4. Vaz M, Jennings G, Turner A, Cox H, Lambert G, Esler M. Regional sympathetic nervous activity and oxygen consumption in obese normo-tensive human subjects. Circulation. 1997;96:3423-3429.
5. Alvarez GE, Beske SD, Ballard TP, Davy KP. Sympathetic neural activation in visceral obesity. Circulation. 2002;106:2533-2536.
6. Grassi G, Seravalle G, Cattaneo BM, Bolla GB, Lanfranchi A, Colombo M, Giannattasio C, Brunani A, Cavagnini F, Mancia G. Sympathetic activation in obese normotensive subjects. Hypertension. 1995;25: 560-563.
7. Shibao C, Gamboa A, Diedrich A, Ertl AC, Chen KY, Byrne DW, Farley G, Paranjape SY, Davis SN, Biaggioni I. Autonomic contribution to blood pressure and metabolism in obesity. Hypertension. 2007;49:27-33. (Pubitemid 46360337)
8. Boustany CM, Bharadwaj K, Daugherty A, Brown DR, Randall DC, Cassis LA. Activation of the systemic and adipose renin-angiotensin system in rats with diet-induced obesity and hypertension. Am J Physiol Regul Integr Comp Physiol. 2004;287:R943-R949.
9. Levin BE. Sympathetic activity, age, sucrose preference, and diet-induced obesity. Obes Res. 1993;1:281-287.
10. Stocker SD, Meador R, Adams JM. Neurons of the rostral ventrolateral medulla contribute to obesity-induced hypertension in rats. Hypertension. 2007;49:640-646.
11. Anderson EA, Hoffman RP, Balon TW, Sinkey CA, Mark AL. Hyper-insulinemia produces both sympathetic neural activation and vasodilation in normal humans. J Clin Invest. 1991;87:2246-2252.
12. Morgan DA, Balon TW, Ginsberg BH, Mark AL. Nonuniform regional sympathetic nerve responses to hyperinsulinemia in rats. Am J Physiol Regul Integr Comp Physiol. 1993;264:R423-R427.
13. Muntzel M, Beltz T, Mark AL, Johnson AK. Anteroventral third ventricle lesions abolish lumbar sympathetic responses to insulin. Hypertension. 1994;23:1059-1062.
14. Muntzel MS, Morgan DA, Mark AL, Johnson AK. Intracerebroventric-ular insulin produces nonuniform regional increases in sympathetic nerve activity. Am J Physiol Regul Integr Comp Physiol. 1994;267: R1350-R1355.
15. Brands MW, Lee WF, Keen HL, Alonso-Galicia M, Zappe DH, Hall JE. Cardiac output and renal function during insulin hypertension in Spra-gue-Dawley rats. Am J Physiol Regul Integr Comp Physiol. 1996;271: R276-R281.
16. Guyenet PG. The sympathetic control of blood pressure. Nat Rev Neurosci. 2006;7:335-346.
17. Ito S, Komatsu K, Tsukamoto K, Sved AF. Excitatory amino acids in the rostral ventrolateral medulla support blood pressure in spontaneously hypertensive rats. Hypertension. 2000;35:413-417.
18. Ito S, Komatsu K, Tsukamoto K, Sved AF. Tonic excitatory input to the rostral ventrolateral medulla in Dahl salt-sensitive rats. Hypertension. 2001;37:687-691.
19. Bergamaschi C, Campos RR, Schor N, Lopes OU. Role of the rostral ventrolateral medulla in maintenance of blood pressure in rats with Goldblatt hypertension. Hypertension. 1995;26:1117-1120.
20. Song K, Allen AM, Paxinos G, Mendelsohn FA. Angiotensin II receptor subtypes in rat brain. Clin Exp Pharmacol Physiol. 1991;18:93-96.
21. Dampney RA, Fontes MA, Hirooka Y, Horiuchi J, Potts PD, Tagawa T. Role of angiotensin II receptors in the regulation of vasomotor neurons in the ventrolateral medulla. Clin Exp Pharmacol Physiol. 2002;29: 467-472.
22. Nakata T, Takeda K, Hatta T, Kiyama M, Moriguchi J, Miki S, Kawa T, Morimoto S, Nakamura K, Uchida A, Itoh H, Sasaki S, Nakagawa M. Blockade of angiotensin II receptors inhibits the increase in blood pressure induced by insulin. J Cardiovasc Pharmacol. 1998;31:248-252.
23. Brands MW, Harrison DL, Keen HL, Gardner A, Shek EW, Hall JE. Insulin-induced hypertension in rats depends on an intact renin-angioten-sin system. Hypertension. 1997;29:1014-1019.
24. Adan RA, Gispen WH. Melanocortins and the brain: from effects via receptors to drug targets. Eur J Pharmacol. 2000;405:13-24.
25. Kawabe T, Chitravanshi VC, Kawabe K, Sapru HN. Cardiovascular effects of adrenocorticotropin microinjections into the rostral ventro-lateral medullary pressor area of the rat. Brain Res. 2006;1102:117-126.
26. Rahmouni K, Haynes WG, Morgan DA, Mark AL. Role of melanocortin-4 receptors in mediating renal sympathoactivation to leptin and insulin. J Neurosci. 2003;23:5998-6004.
27. Scislo TJ, Augustyniak RA, O'Leary DS. Differential arterial baroreflex regulation of renal, lumbar, and adrenal sympathetic nerve activity in the rat. Am J Physiol Regul Integr Comp Physiol. 1998;275:R995-R1002.
28. Stocker SD, Hunwick KJ, Toney GM. Hypothalamic paraventricular nucleus differentially supports lumbar and renal sympathetic outflow in water-deprived rats. J Physiol. 2005;563:249-263.
29. Adams JM, Madden CJ, Sved AF, Stocker SD. Increased dietary salt enhances sympathoexcitatory and sympathoinhibitory responses from the rostral ventrolateral medulla. Hypertension. 2007;50:354-359.
30. Adams JM, McCarthy JJ, Stocker SD. Excess dietary salt alters angio-tensinergic regulation of neurons in the rostral ventrolateral medulla. Hypertension. 2008;52:932-937.
31. Kiely JM, Gordon FJ. Role of rostral ventrolateral medulla in centrally mediated pressor responses. Am J Physiol Heart Circ Physiol. 1994;267: H1549-H1556.
32. Kawabe T, Chitravanshi VC, Kawabe K, Sapru HN. Cardiovascular function of a glutamatergic projection from the hypothalamic paraven-tricular nucleus to the nucleus tractus solitarius in the rat. Neuroscience. 2008;153:605-617.
33. Madden CJ, Morrison SF. Excitatory amino acid receptor activation in the raphe pallidus area mediates prostaglandin-evoked thermogenesis. Neu-roscience. 2003;122:5-15.
34. Rahmouni K, Morgan DA, Morgan GM, Liu X, Sigmund CD, Mark AL, Haynes WG. Hypothalamic PI3K and MAPK differentially mediate regional sympathetic activation to insulin. J Clin Invest. 2004;114: 652-658.
35. Stocker SD, Smith CA, Kimbrough CM, Stricker EM, Sved AF. Elevated dietary salt suppresses renin secretion but not thirst evoked by arterial hypotension in rats. Am J Physiol Regul Integr Comp Physiol. 2003;284: R1521-R1528.
36. Anderson EA, Balon TW, Hoffman RP, Sinkey CA, Mark AL. Insulin increases sympathetic activity but not blood pressure in borderline hypertensive humans. Hypertension. 1992;19:621-627.
37. Boustany CM, Brown DR, Randall DC, Cassis LA. AT1-receptor antagonism reverses the blood pressure elevation associated with diet-induced obesity. Am J Physiol Regul Integr Comp Physiol. 2005;289: R181-R186.
38. Dobrian AD, Davies MJ, Prewitt RL, Lauterio TJ. Development of hypertension in a rat model of diet-induced obesity. Hypertension. 2000; 35:1009-1015.
39. Levin BE, Keesey RE. Defense of differing body weight set points in diet-induced obese and resistant rats. Am J Physiol Regul Integr Comp Physiol. 1998;274:R412-R419.
40. Levin BE, Triscari J, Sullivan AC. Altered sympathetic activity during development of diet-induced obesity in rat. Am J Physiol Regul Integr Comp Physiol. 1983;244:R347-R355.
41. Stocker SD, Simmons JR, Stornetta RL, Toney GM, Guyenet PG. Water deprivation activates a glutamatergic projection from the hypothalamic paraventricular nucleus to the rostral ventrolateral medulla. J Comp Neurol. 2006;494:673-685.
42. Stocker SD, Bardgett ME. Hypothalamic paraventricular nucleus contributes to the sympathoexcitatory effects of hyperinsulinemia. 61st Annual High Blood Pressure Conference 2007. Hypertension. 2007; 49:e79. Abstract.
43. Werther GA, Hogg A, Oldfield BJ, McKinley MJ, Figdor R, Allen AM, Mendelsohn FA. Localization and characterization of insulin receptors in rat brain and pituitary gland using in vitro autoradiography and computerized densitometry. Endocrinology. 1987;121:1562-1570.
44. Brands MW, Mizelle HL, Gaillard CA, Hildebrandt DA, Hall JE. The hemodynamic response to chronic hyperinsulinemia in conscious dogs. Am J Hypertens. 1991;4:164-168.
45. Hildebrandt DA, Smith MJ Jr, Hall JE. Cardiovascular regulation during insulin infusion into the carotid or vertebral artery in dogs. J Hypertens. 1999;17:251-260.